Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Experimental & Molecular Medicine ; : 347-352, 2002.
Artigo em Inglês | WPRIM | ID: wpr-203702

RESUMO

Osteoprotegerin (OPG), a member of the tumor necrosis factor receptor superfamily, is known to inhibit osteoclastogenesis by acting as a soluble decoy receptor for the receptor activator of NF-kB ligand (RANKL). We report the presence of OPG on the membrane of osteoclasts and the possibility of the direct action of OPG on them. Highly pure osteoclast precursors were isolated from mouse long bones and induced to differentiate into mature osteoclasts by M-CSF and soluble RANKL (sRANKL). The presence of OPG on the membrane of these cells was confirmed by western blotting and immunostaining. Furthermore, sRANKL was found to be bound to the OPG on the osteoclast precursors. These results suggest that OPG might have a new role during the differentiation of osteoclasts beyond its role as a soluble decoy receptor. The mechanism of the existence of OPG on osteoclast precursors remains to be found.


Assuntos
Animais , Camundongos , Osso e Ossos/citologia , Proteínas de Transporte/imunologia , Diferenciação Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Células Cultivadas , Glicoproteínas/efeitos dos fármacos , Fator Estimulador de Colônias de Macrófagos/farmacologia , Glicoproteínas de Membrana/imunologia , Camundongos Endogâmicos ICR , Osteoclastos/efeitos dos fármacos , Receptores Citoplasmáticos e Nucleares/efeitos dos fármacos , Células-Tronco/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA